<SEC-DOCUMENT>0001104659-25-002584-index.html : 20250110 <SEC-HEADER>0001104659-25-002584.hdr.sgml : 20250110 <ACCEPTANCE-DATETIME>20250110164654 ACCESSION NUMBER: 0001104659-25-002584 CONFORMED SUBMISSION TYPE: PRER14A PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20250110 DATE AS OF CHANGE: 20250110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRER14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 25523610 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 </SEC-HEADER> <DOCUMENT> <TYPE>PRER14A <SEQUENCE>1 <FILENAME>tm252001-2_prer14a.htm <DESCRIPTION>PRER14A <TEXT> Document 1 - file: tm252001-2_prer14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>lg_cyclacel-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: lg_cyclacel-4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>sg_jeffreywbullock-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: sg_jeffreywbullock-bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>lg_secretarysoffistamp-bwlr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: lg_secretarysoffistamp-bwlr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>px_cyclacel25pg01-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: px_cyclacel25pg01-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>px_cyclacel25pg02-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: px_cyclacel25pg02-4c.jpg
</DOCUMENT> </SEC-DOCUMENT>